Hormone-like (endocrine) Fgfs: Their evolutionary history and roles in development, metabolism, and disease

Cell and Tissue Research

Volumn 342, Issue 1, 2010, Pages 1-11

  Itoh, Nobuyuki ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Disease; Endocrine; Evolution; Fgf; Metabolism

Indexed keywords

ALPHA KLOTHO PROTEIN; BETA KLOTHO PROTEIN; CHOLESTEROL 7ALPHA MONOOXYGENASE; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; FIBROBLAST GROWTH FACTOR 19; FIBROBLAST GROWTH FACTOR 21; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR 4; KLOTHO PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; SOMATOMEDIN; TRANSCRIPTION FACTOR PBX1; UNCLASSIFIED DRUG;

BINDING AFFINITY; BINDING SITE; EMBRYO DEVELOPMENT; GENE DUPLICATION; GENE LOCUS; GENE MUTATION; GENETIC DISORDER; HUMAN; INSULIN RESISTANCE; LIPID METABOLISM; METABOLIC DISORDER; MISSENSE MUTATION; MOLECULAR EVOLUTION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PARANEOPLASTIC SYNDROME; PHENOTYPE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN STRUCTURE; SHORT SURVEY; SIGNAL TRANSDUCTION; WHITE ADIPOSE TISSUE;

ADIPOSE TISSUE; ANIMALS; BILE ACIDS AND SALTS; EVOLUTION, MOLECULAR; FIBROBLAST GROWTH FACTORS; GENE DUPLICATION; GLUCURONIDASE; HUMANS; LIPID METABOLISM; LIVER; METABOLIC DISEASES; NEOPLASMS; PEPTIDE HORMONES; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; VITAMIN D;

INVERTEBRATA; VERTEBRATA;

EID: 77955814651     PISSN: 0302766X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00441-010-1024-2     Document Type: Short Survey

References (81)

1. ADHR Consortium 2000 Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23 Nat Genet 26 345 348 10.1038/81664
2. MK Badman P Pissios AR Kennedy G Koukos JS Flier E Maratos-Flier 2007 Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states Cell Metab 5 426 437 1:CAS:528:DC%2BD2sXmslOqsrY%3D 10.1016/j.cmet.2007.05.002 17550778
3. MK Badman A Koester JS Flier A Kharitonenkov E Maratos-Flier 2009 Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis Endocrinology 150 4931 4940 1:CAS:528:DC%2BD1MXhsVCht7nL 10.1210/en.2009-0532 19819944
4. A Beenken M Mohammadi 2009 The FGF family: biology, pathophysiology and therapy Nat Rev Drug Discov 8 235 253 1:CAS:528:DC%2BD1MXisVShur4%3D 10.1038/nrd2792 19247306
5. A Benet-Pagès P Orlik TM Strom B Lorenz-Depiereux 2005 An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia Hum Mol Genet 14 385 390 10.1093/hmg/ddi034 15590700
6. WW Chen L Li GY Yang K Li XY Qi W Zhu Y Tang H Liu G Boden 2008 Circulating FGF-21 levels in normal subjects and in newly diagnose patients with Type 2 diabetes mellitus Exp Clin Endocrinol Diabetes 116 65 68 1:CAS:528:DC%2BD1cXjslCjsbw%3D 10.1055/s-2007-985148 17926232
7. I Dostálová P Kaválková D Haluzíková Z Lacinová M Mráz H Papezová M Haluzík 2008 Plasma concentrations of fibroblast growth factors 19 and 21 in patients with anorexia nervosa J Clin Endocrinol Metab 3 3627 3632 10.1210/jc.2008-0746
8. Durovcová V, Marek J, Hána V, Matoulek M, Zikán V, Haluzíková D, Kaválková P, Lacinová Z, Kršek M, Haluzík M (2010) Plasma concentrations of fibroblast growth factors 21 and 19 in patients with Cushing's syndrome. Physiol Res (in press)
9. Y Frishberg O Topaz R Bergman D Behar D Fisher D Gordon G Richard E Sprecher 2005 Identification of a recurrent mutation in GALNT3 demonstrates that hyperostosis-hyperphosphatemia syndrome and familial tumoral calcinosis are allelic disorders J Mol Med 83 33 38 1:CAS:528:DC%2BD2MXisFCjsw%3D%3D 10.1007/s00109-004-0610-8 15599692
10. Y Frishberg N Ito C Rinat Y Yamazaki S Feinstein I Urakawa P Navon-Elkan R Becker-Cohen T Yamashita K Araya T Igarashi T Fujita S Fukumoto 2007 Hyperostosis-hyperphosphatemia syndrome: a congenital disorder of O-glycosylation associated with augmented processing of fibroblast growth factor 23 J Bone Miner Res 22 235 242 1:CAS:528:DC%2BD2sXhvFCgs7w%3D 10.1359/jbmr.061105 17129170
11. S Fukumoto 2009 The role of bone in phosphate metabolism Mol Cell Endocrinol 310 63 70 1:CAS:528:DC%2BD1MXhtVKlsrzN 10.1016/j.mce.2008.08.031 18822343
12. R Goetz A Beenken OA Ibrahimi J Kalinina SK Olsen AV Eliseenkova C Xu TA Neubert F Zhang RJ Linhardt X Yu KE White T Inagaki SA Kliewer M Yamamoto H Kurosu Y Ogawa M Kuro-o B Lanske MS Razzaque M Mohammadi 2007 Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members Mol Cell Biol 27 3417 3428 1:CAS:528:DC%2BD2sXltFCksLY%3D 10.1128/MCB.02249-06 17339340
13. M Goldfarb 2005 Fibroblast growth factor homologous factors: evolution, structure, and function Cytokine Growth Factor Rev 16 215 220 1:CAS:528:DC%2BD2MXjvVOnsL0%3D 10.1016/j.cytogfr.2005.02.002 15863036
14. M Goldfarb J Schoorlemmer A Williams S Diwakar Q Wang X Huang J Giza D Tchetchik K Kelley A Vega G Matthews P Rossi DM Ornitz E D'Angelo 2007 Fibroblast growth factor homologous factors control neuronal excitability through modulation of voltage-gated sodium channels Neuron 55 449 463 1:CAS:528:DC%2BD2sXpsVGltrc%3D 10.1016/j.neuron.2007.07.006 17678857
15. Y Hotta H Nakamura M Konishi Y Murata H Takagi S Matsumura K Inoue T Fushiki N Itoh 2009 Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver Endocrinology 150 4625 4633 1:CAS:528:DC%2BD1MXht1OktrrI 10.1210/en.2009-0119 19589869
16. S Ichikawa AH Sorenson AM Austin DS Mackenzie TA Fritz A Moh SL Hui MJ Econs 2009 Ablation of the Galnt3 gene leads to low-circulating intact fibroblast growth factor 23 (Fgf23) concentrations and hyperphosphatemia despite increased Fgf23 expression Endocrinology 150 2543 2550 1:CAS:528: DC%2BD1MXmvVCqt7c%3D 10.1210/en.2008-0877 19213845
17. Y Imanishi M Inaba K Nakatsuka K Nagasue S Okuno A Yoshihara M Miura A Miyauchi K Kobayashi T Miki T Shoji E Ishimura Y Nishizawa 2004 FGF-23 in patients with end-stage renal disease on hemodialysis Kidney Int 65 1943 1946 1:CAS:528:DC%2BD2cXktl2gur8%3D 10.1111/j.1523-1755.2004.00604.x 15086938
18. T Inagaki M Choi A Moschetta L Peng CL Cummins JG McDonald G Luo SA Jones B Goodwin JA Richardson RD Gerard JJ Repa DJ Mangelsdorf SA Kliewer 2005 Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis Cell Metab 2 217 225 1:CAS:528:DC%2BD2MXhtFGktrjM 10.1016/j.cmet.2005.09.001 16213224
19. T Inagaki P Dutchak G Zhao X Ding L Gautron V Parameswara Y Li R Goetz M Mohammadi V Esser JK Elmquist RD Gerard SC Burgess RE Hammer DJ Mangelsdorf SA Kliewer 2007 Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21 Cell Metab 5 415 425 1:CAS:528:DC%2BD2sXmslOqsrk%3D 10.1016/j.cmet.2007.05.003 17550777
20. T Inagaki VY Lin R Goetz M Mohammadi DJ Mangelsdorf SA Kliewer 2008 Inhibition of growth hormone signaling by the fasting-induced hormone FGF21 Cell Metab 8 77 83 1:CAS:528:DC%2BD1cXotlymsro%3D 10.1016/j.cmet.2008.05.006 18585098
21. S Ito S Kinoshita N Shiraishi S Nakagawa S Sekine T Fujimori YI Nabeshima 2000 Molecular cloning and expression analyses of mouse betaklotho, which encodes a novel Klotho family protein Mech Dev 98 115 119 1:CAS:528: DC%2BD3cXot12qtb0%3D 10.1016/S0925-4773(00)00439-1 11044614
22. S Ito T Fujimori A Furuya J Satoh Y Nabeshima Y Nabeshima 2005 Impaired negative feedback suppression of bile acid synthesis in mice lacking betaKlotho J Clin Invest 115 2202 2208 1:CAS:528:DC%2BD2MXntFCmtbs%3D 10.1172/JCI23076 16075061
23. N Itoh 2007 The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease Biol Pharm Bull 30 1819 1825 1:CAS:528:DC%2BD2sXhtl2jtLnJ 10.1248/bpb.30.1819 17917244
24. N Itoh M Konishi 2007 The zebrafish fgf family Zebrafish 4 179 186 1:CAS:528:DC%2BD2sXht1yku7vE 10.1089/zeb.2007.0509 18041922
25. N Itoh DM Ornitz 2004 Evolution of the Fgf and Fgfr gene families Trends Genet 20 563 569 1:CAS:528:DC%2BD2cXotlajsLo%3D 10.1016/j.tig.2004.08.007 15475116
26. N Itoh DM Ornitz 2008 Functional evolutionary history of the mouse Fgf gene family Dev Dyn 237 18 27 1:CAS:528:DC%2BD1cXhvFGlu78%3D 10.1002/dvdy.21388 18058912
27. CL Johnson JY Weston SA Chadi EN Fazio MW Huff A Kharitonenkov A Köester CL Pin 2009 Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice Gastroenterology 137 1795 1804 1:CAS:528:DC%2BD1MXhsVyhsbzK 10.1053/j.gastro.2009.07.064 19664632
28. K Kato C Jeanneau MA Tarp A Benet-Pagès B Lorenz-Depiereux EP Bennett U Mandel TM Strom H Clausen 2006 Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation J Biol Chem 281 18370 18377 1:CAS:528:DC%2BD28XmsVagsbg%3D 10.1074/jbc.M602469200 16638743
29. S Kersten J Seydoux JM Peters FJ Gonzalez B Desvergne W Wahli 1999 Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting J Clin Invest 103 1489 1498 1:CAS:528:DyaK1MXjvVSntLo%3D 10.1172/JCI6223 10359558
30. A Kharitonenkov 2009 FGFs and metabolism Curr Opin Pharmacol 9 805 810 1:CAS:528:DC%2BD1MXhsVGqs7jN 10.1016/j.coph.2009.07.001 19683963
31. A Kharitonenkov AB Shanafelt 2009 FGF21: a novel prospect for the treatment of metabolic diseases Curr Opin Investig Drugs 10 359 364 1:CAS:528:DC%2BC3cXnt1Kiurk%3D 19337957
32. A Kharitonenkov TL Shiyanova A Koester AM Ford R Micanovic EJ Galbreath GE Sandusky LJ Hammond JS Moyers RA Owens J Gromada JT Brozinick ED Hawkins VJ Wroblewski DS Li F Mehrbod SR Jaskunas AB Shanafelt 2005 FGF-21 as a novel metabolic regulator J Clin Invest 115 1627 1635 1:CAS:528:DC%2BD2MXkvF2lsrs%3D 10.1172/JCI23606 15902306
33. A Kharitonenkov JD Dunbar HA Bina S Bright JS Moyers C Zhang L Ding R Micanovic SF Mehrbod MD Knierman JE Hale T Coskun AB Shanafelt 2008 FGF-21/FGF-21 receptor interaction and activation is determined by betaKlotho J Cell Physiol 215 1 7 1:CAS:528:DC%2BD1cXjt1Cgsrk%3D 10.1002/jcp.21357 18064602
34. P Krejci J Prochazkova V Bryja A Kozubik WR Wilcox 2009 Molecular pathology of the fibroblast growth factor family Hum Mutat 30 1245 1255 1:CAS:528:DC%2BD1MXhtFyqtL7P 10.1002/humu.21067 19621416
35. M Kuro-o 2008 Endocrine FGFs and Klothos: emerging concepts Trends Endocrinol Metab 19 239 245 1:CAS:528:DC%2BD1cXhtVeisrfL 10.1016/j.tem.2008.06. 002 18692401
36. M Kuro-o Y Matsumura H Aizawa H Kawaguchi T Suga T Utsugi Y Ohyama M Kurabayashi T Kaname E Kume H Iwasaki A Iida T Shiraki-Iida S Nishikawa R Nagai YI Nabeshima 1997 Mutation of the mouse klotho gene leads to a syndrome resembling ageing Nature 390 45 51 1:CAS:528:DyaK2sXnt1Cnu70%3D 10.1038/36285 9363890
37. H Kurosu M Kuro-o 2009 Endocrine fibroblast growth factors as regulators of metabolic homeostasis Biofactors 35 52 60 1:CAS:528:DC%2BD1MXnsVSmtbg%3D 10.1002/biof.12 19319846
38. H Kurosu Y Ogawa M Miyoshi M Yamamoto A Nandi KP Rosenblatt MG Baum S Schiavi MC Hu OW Moe M Kuro-o 2006 Regulation of fibroblast growth factor-23 signaling by klotho J Biol Chem 281 6120 6123 1:CAS:528:DC%2BD28XhvFOhtLk%3D 10.1074/jbc.C500457200 16436388
39. H Kurosu M Choi Y Ogawa AS Dickson R Goetz AV Eliseenkova M Mohammadi KP Rosenblatt SA Kliewer M Kuro-o 2007 Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21 J Biol Chem 282 26687 2695 1:CAS:528:DC%2BD2sXhtVWjsL3K 10.1074/jbc.M704165200 17623664
40. T Larsson U Nisbeth O Ljunggren H Jüppner KB Jonsson 2003 Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers Kidney Int 64 2272 2279 1:CAS:528:DC%2BD3sXpvFOqtLw%3D 10.1046/j.1523-1755.2003.00328.x 14633152
41. TC Leone CJ Weinheimer DP Kelly 1999 A critical role for the peroxisome proliferator-activated receptor alpha (PPARalpha) in the cellular fasting response: the PPARalpha-null mouse as a model of fatty acid oxidation disorders Proc Natl Acad Sci USA 96 7473 7478 1:CAS:528:DyaK1MXltVOqs7k%3D 10.1073/pnas.96.13.7473 10377439
42. S Liu J Zhou W Tang R Menard JQ Feng LD Quarles 2008 Pathogenic role of Fgf23 in Dmp1-null mice Am J Physiol Endocrinol Metab 295 E254 E261 1:CAS:528:DC%2BD1cXhtVaktr3P 10.1152/ajpendo.90201.2008 18559986
43. B Lorenz-Depiereux M Bastepe A Benet-Pagès M Amyere J Wagenstaller U Müller-Barth K Badenhoop SM Kaiser RS Rittmaster AH Shlossberg JL Olivares C Loris FJ Ramos F Glorieux M Vikkula H Jüppner TM Strom 2006 DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis Nat Genet 38 1248 1250 1:CAS:528:DC%2BD28XhtFeisbvN 10.1038/ng1868 17033625
44. JR McWhirter M Goulding JA Weiner J Chun C Murre 1997 A novel fibroblast growth factor gene expressed in the developing nervous system is a downstream target of the chimeric homeodomain oncoprotein E2A-Pbx1 Development 124 3221 3232 1:CAS:528:DyaK2sXmtleks7o%3D 9310317
45. RG Melvin MT Andrews 2009 Torpor induction in mammals: recent discoveries fueling new ideas Trends Endocrinol Metab 20 490 498 1:CAS:528: DC%2BD1MXhsVGrur3J 10.1016/j.tem.2009.09.005 19864159
46. AJ Mikels R Nusse 2006 Wnts as ligands: processing, secretion and reception Oncogene 25 7461 7468 1:CAS:528:DC%2BD28Xht1Kgt7%2FM 10.1038/sj.onc.1210053 17143290
47. A Miyake Y Nakayama M Konishi N Itoh 2005 Fgf19 regulated by Hh signaling is required for zebrafish forebrain development Dev Biol 288 259 275 1:CAS:528:DC%2BD2MXht1OltbzI 10.1016/j.ydbio.2005.09.042 16256099
48. DD Moore 2007 Physiology. Sister act Science 316 1436 1438 1:CAS:528:DC%2BD2sXmsFyhtrk%3D 10.1126/science.1144837 17556573
49. JS Moyers TL Shiyanova F Mehrbod JD Dunbar TW Noblitt KA Otto A Reifel-Miller A Kharitonenkov 2007 Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling J Cell Physiol 210 1 6 1:CAS:528:DC%2BD28XhtlWktrvJ 10.1002/jcp.20847 17063460
50. M Mraz M Bartlova Z Lacinova D Michalsky M Kasalicky D Haluzikova M Matoulek I Dostalova V Humenanska M Haluzik 2009 Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity Clin Endocrinol 71 369 375 1:CAS:528:DC%2BD1MXhtFagtL%2FO 10.1111/j.1365-2265.2008.03502.x
51. Y Nakayama A Miyake Y Nakagawa T Mido M Yoshikawa M Konishi N Itoh 2008 Fgf19 is required for zebrafish lens and retina development Dev Biol 313 752 766 1:CAS:528:DC%2BD1cXlsFKhsg%3D%3D 10.1016/j.ydbio.2007.11.013 18089288
52. T Nishimura Y Utsunomiya M Hoshikawa H Ohuchi N Itoh 1999 Structure and expression of a novel human FGF, FGF-19, expressed in the fetal brain Biochim Biophys Acta 1444 148 151 1:CAS:528:DyaK1MXnslOrtw%3D%3D 9931477
53. T Nishimura Y Nakatake M Konishi N Itoh 2000 Identification of a novel FGF, FGF-21, preferentially expressed in the liver Biochim Biophys Acta 492 203 206
54. Y Ogawa H Kurosu M Yamamoto A Nandi KP Rosenblatt R Goetz AV Eliseenkova M Mohammadi M Kuro-o 2007 BetaKlotho is required for metabolic activity of fibroblast growth factor 21 Proc Natl Acad Sci USA 104 7432 7437 1:CAS:528:DC%2BD2sXlslGhtr4%3D 10.1073/pnas.0701600104 17452648
55. K Oishi K Sakamoto M Konishi Y Murata N Itoh H Sei 2010 FGF21 is dispensable for hypothermia induced by fasting in mice Neuro Endocrinol Lett 31 198 202 1:CAS:528:DC%2BC3cXns1Cju7w%3D 20424589
56. MJ Potthoff T Inagaki S Satapati X Ding T He R Goetz M Mohammadi BN Finck DJ Mangelsdorf SA Kliewer SC Burgess 2009 FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response Proc Natl Acad Sci USA 106 10853 10858 1:CAS:528:DC%2BD1MXos1Sjs74%3D 10.1073/pnas.0904187106 19541642
57. MS Razzaque 2009 The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis Nat Rev Endocrinol 5 611 619 1:CAS:528:DC%2BD1MXht1ymsL7E 10.1038/nrendo.2009.196 19844248
58. M Reiche A Bachmann U Lössner M Blüher M Stumvoll M Fasshauer 2010 Fibroblast growth factor 19 serum levels: relation to renal function and metabolic parameters Horm Metab Res 42 178 181 1:CAS:528:DC%2BC3cXltFShur4%3D 10.1055/s-0029-1243249 20013647
59. Y Satou KS Imai N Satoh 2002 Fgf genes in the basal chordate Ciona intestinalis Dev Genes Evol 212 432 438 1:CAS:528:DC%2BD38XpsV2msrw%3D 10.1007/s00427-002-0266-8 12373588
60. FG Schaap NA van der Gaag DJ Gouma PL Jansen 2009 High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis Hepatology 49 1228 1235 1:CAS:528:DC%2BD1MXkslWjsro%3D 10.1002/hep.22771 19185005
61. TC Schreuder HA Marsman M Lenicek JR van Werven AJ Nederveen PL Jansen FG Schaap 2010 The hepatic response to FGF19 is impaired in patients with nonalcoholic fatty liver disease and insulin resistance Am J Physiol Gastrointest Liver Physiol 298 G440 G445 1:CAS:528:DC%2BC3cXjsFGgt7c%3D 10.1152/ajpgi.00322.2009 20093562
62. T Shimada S Mizutani T Muto T Yoneya R Hino S Takeda Y Takeuchi T Fujita S Fukumoto T Yamashita 2001 Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia Proc Natl Acad Sci USA 98 6500 6505 1:CAS:528:DC%2BD3MXktVWktLs%3D 10.1073/pnas.101545198 11344269
63. T Shimada M Kakitani Y Yamazaki H Hasegawa Y Takeuchi T Fujita S Fukumoto K Tomizuka T Yamashita 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism J Clin Invest 113 561 568 1:CAS:528:DC%2BD2cXhsFKhsbs%3D 14966565
64. M Suzuki Y Uehara K Motomura-Matsuzaka J Oki Y Koyama M Kimura M Asada A Komi-Kuramochi S Oka T Imamura 2008 betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c Mol Endocrinol 22 1006 1014 1:CAS:528:DC%2BD1cXkt1Cntr8%3D 10.1210/me.2007-0313 18187602
65. B Thisse C Thisse 2005 Functions and regulations of fibroblast growth factor signaling during embryonic development Dev Biol 287 390 402 1:CAS:528:DC%2BD2MXht1GhtL%2FF 10.1016/j.ydbio.2005.09.011 16216232
66. JP Thissen LE Underwood JM Ketelslegers 1999 Regulation of insulin-like growth factor-I in starvation and injury Nutr Rev 57 167 176 1:STN:280:DyaK1MzmvVCrtg%3D%3D 10.1111/j.1753-4887.1999.tb06939.x 10439629
67. K Tomiyama R Maeda I Urakawa Y Yamazaki T Tanaka S Ito Y Nabeshima T Tomita S Odori K Hosoda K Nakao A Imura Y Nabeshima 2010 Relevant use of Klotho in FGF19 subfamily signaling system in vivo Proc Natl Acad Sci USA 107 1666 1671 1:CAS:528:DC%2BC3cXhslGnsbk%3D 10.1073/pnas.0913986107 20080590
68. E Tomlinson L Fu L John B Hultgren X Huang M Renz JP Stephan SP Tsai L Powell-Braxton D French TA Stewart 2002 Transgenic mice expressing human fibroblast growth factor-19 display increased metabolic rate and decreased adiposity Endocrinology 143 1741 1747 1:CAS:528:DC%2BD38XjtFOjsL0%3D 10.1210/en.143.5.1741 11956156
69. O Topaz DL Shurman R Bergman M Indelman P Ratajczak M Mizrachi Z Khamaysi D Behar D Petronius V Friedman I Zelikovic S Raimer A Metzker G Richard E Sprecher 2004 Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis Nat Genet 36 579 581 1:CAS:528:DC%2BD2cXksVajt78%3D 10.1038/ng1358 15133511
70. H Tsujikawa Y Kurotaki T Fujimori K Fukuda Y Nabeshima 2003 Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system Mol Endocrinol 17 2393 2403 1:CAS:528:DC%2BD3sXpvFCktr8%3D 10.1210/me.2003-0048 14528024
71. I Urakawa Y Yamazaki T Shimada K Iijima H Hasegawa K Okawa T Fujita S Fukumoto T Yamashita 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23 Nature 444 770 774 1:CAS:528:DC%2BD28Xht1OntbzF 10.1038/nature05315 17086194
72. JW Vincentz JR McWhirter C Murre A Baldini Y Furuta 2005 Fgf15 is required for proper morphogenesis of the mouse cardiac outflow tract Genesis 41 192 201 1:CAS:528:DC%2BD2MXltVWgs70%3D 10.1002/gene.20114 15789410
73. W Wente AM Efanov M Brenner A Kharitonenkov A Köster GE Sandusky S Sewing I Treinies H Zitzer J Gromada 2006 Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1/2 and Akt signaling pathways Diabetes 55 2470 2478 1:CAS:528:DC%2BD28XpsVOrtL8%3D 10.2337/db05-1435 16936195
74. KE White G Carn B Lorenz-Depiereux A Benet-Pages TM Strom MJ Econs 2001 Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23 Kidney Int 60 2079 2086 1:CAS:528:DC%2BD3MXpt1Kjsrs%3D 10.1046/j.1523-1755.2001. 00064.x 11737582
75. M Xiao L Xu F Laezza K Yamada S Feng DM Ornitz 2007 Impaired hippocampal synaptic transmission and plasticity in mice lacking fibroblast growth factor 14 Mol Cell Neurosci 34 366 377 1:CAS:528:DC%2BD2sXisVCnsbc%3D 10.1016/j.mcn.2006.11.020 17208450
76. Xie MH, Holcomb I, Deuel B, Dowd P, Huang A, Vagts A, Foster J, Liang J, Brush J, Gu Q, Hillan K, Goddard A, Gurney AL (1999) FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine11:729-735
77. T Yamashita M Yoshioka N Itoh 2000 Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain Biochem Biophys Res Commun 277 494 498 1:CAS:528: DC%2BD3cXntlGit70%3D 10.1006/bbrc.2000.3696 11032749
78. H Yamauchi Y Hotta M Konishi A Miyake A Kawahara N Itoh 2006 Fgf21 is essential for haematopoiesis in zebrafish EMBO Rep 7 649 654 1:CAS:528:DC%2BD28Xlt1ahu7g%3D 16612391
79. C Yu F Wang M Kan C Jin RB Jones M Weinstein CX Deng WL McKeehan 2000 Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4 J Biol Chem 275 15482 15489 1:CAS:528: DC%2BD3cXjsFamsb4%3D 10.1074/jbc.275.20.15482 10809780
80. X Zhang OA Ibrahimi SK Olsen H Umemori M Mohammadi DM Ornitz 2006 Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family J Biol Chem 281 15694 1700 1:CAS:528:DC%2BD28Xlt1Cktrc%3D 10.1074/jbc.M601252200 16597617
81. X Zhang DC Yeung M Karpisek D Stejskal ZG Zhou F Liu RL Wong WS Chow AW Tso KS Lam A Xu 2008 Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans Diabetes 57 1246 1253 1:CAS:528:DC%2BD1cXlvVKjtL4%3D 10.2337/db07-1476 18252893